Tert-butyl 5-[[1-[(3-aminophenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate
C24H31N5O2 — CID 90119951
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 5-[[1-[(3-aminophenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate
Tert-butyl 5-[[1-[(3-aminophenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate (PubChem CID 90119951) has the molecular formula C24H31N5O2 and a molecular weight of 421.55 g/mol. Its IUPAC name is tert-butyl 5-[[1-[(3-aminophenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 5-[[1-[(3-aminophenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate |
|---|---|
| PubChem CID | 90119951 |
| Molecular Formula | C24H31N5O2 |
| Molecular Weight | 421.55 g/mol |
| Exact Mass | 421.25 |
| IUPAC Name | tert-butyl 5-[[1-[(3-aminophenyl)methyl]piperidin-3-yl]amino]indazole-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)n1ncc2cc(NC3CCCN(Cc4cccc(N)c4)C3)ccc21 |
| InChI | InChI=1S/C24H31N5O2/c1-24(2,3)31-23(30)29-22-10-9-20(13-18(22)14-26-29)27-21-8-5-11-28(16-21)15-17-6-4-7-19(25)12-17/h4,6-7,9-10,12-14,21,27H,5,8,11,15-16,25H2,1-3H3 |
| InChIKey | FUGZLCKHTTYKPE-UHFFFAOYSA-N |
| XLogP | 4.48 |
| TPSA | 85.41 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 421.55 |
| LogP ≤ 5 | 4.48 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aniline', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90119951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.